Results 31 to 40 of about 42,196 (291)
Computational Study of Benzimidazole Derivatives as Potential Antifungal Drugs
Proceedings, 2019 The infection of fungal diseases has increased in these last years due to the rise in immunodeficient patients, the resistance to current drugs, and the lack of design of new and efficient molecules against those pathogens [1]. [...]
Dorian Acevedo, Gian Pietro MIscione
doaj +1 more source
Oral candidiasis-adhesion of non-albicans Candida species [PDF]
Zbornik Matice Srpske za Prirodne Nauke, 2008 Oral candidiasis is an opportunistic infection caused primarily by Candida albicans. However, in recent years, species of non-albicans Candida have been implicated more frequently in mucosal infection.
Bokor-Bratić Marija B.
doaj +1 more source
Hydroxytyrosol (HT) Analogs Act as Potent Antifungals by Direct Disruption of the Fungal Cell Membrane [PDF]
, 2018 Fungal infections constitute an emerging threat and a prevalent health problem due to increasing number of immunocompromised people and pharmacological or other treatments aiming at viral infections, cancer or allergies. Currently used antifungals suffer
Ioannis K. Kostakis +8 more
core +3 more sources
Antimicrobial Susceptibility Testing for Three Malassezia Species
Microbiology Spectrum, 2023 The Malassezia genus comprises lipid-dependent yeasts that have long been associated with common skin diseases, and have recently been linked with Crohn’s disease and certain cancers.
Brooke Rathie +3 more
doaj +1 more source
In vitro antibacterial activity of azole antifungals against carbapenemresistant Enterobacteriaceae [PDF]
, 2019 Introduction: The frequency of serious bacterial infections has increased due to the high prevalence of HIV, contributing to the increasing rates of multi-drug organisms which include carbapenem-resistant Enterobacteriaceae (CRE).
Ndlovu, T.S. +2 more
core +1 more source
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS
, 2022 Background: Triazole antifungals are widely used as broad-spectrum antifungal activity; however, there are many undetected and unreported adverse events (AEs).
Jing-Lun Zhan +3 more
core +1 more source
Frontiers in Microbiology, 2018 The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species.
Giselle C. de Oliveira Santos +11 more
doaj +1 more source
Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
Pharmaceutics, 2023 Invasive fungal infections increase mortality and morbidity rates worldwide. The treatment of these infections is still limited due to the low bioavailability and toxicity, requiring therapeutic monitoring, especially in the most severe cases ...
Laís de Almeida Campos +8 more
doaj +1 more source
Systematic truncations of chromosome 4 and their responses to antifungals in Candida albicans
, 2021 Background Candida albicans is an opportunistic human fungal pathogen responsible for superficial and systemic life-threatening infections. Treating these infections is challenging as many clinical isolates show increased drug resistance to antifungals ...
Wasim Uddin +3 more
core +1 more source
Frontiers in PharmacologyBackgroundThe use of botanical drugs for treating various disorders has gained increasing attention in recent years, with many studies highlighting the efficacy of botanical antifungals against oral candidiasis.
Nurdiana +7 more
doaj +1 more source